Overcoming Site Challenges in Oncology Trials – An interview with Penny Chipman
In this interview Penny Chipman, Manager of the Clinical Research Program at the Gerald Bronfman Centre for Clinical Research in…
In this interview Penny Chipman, Manager of the Clinical Research Program at the Gerald Bronfman Centre for Clinical Research in…
In my last post we looked at the need for a visionary drug development plan. Today’s post will outline the…
In my last post we looked at the first of three essential assets that your team should look to acquire…
Developing oncology compounds is a constantly evolving process, and with the dramatic rise in costs, making every step count is…
In this interview, Dr. Quincy Chu, Medical Oncologist at the Cross Cancer Institute in Edmonton Alberta, discusses the ways in…
Given the increased focus on speed of activation for oncology studies, sponsors are under pressure to select top-performing investigative sites…
The increased demand for targeted therapeutics has prompted oncology drug developers to uncover innovative solutions to new challenges. Fueled by…
With the volume of medical data doubling every 5 years, the challenge has now become how to derive actionable insights…
Canada boasts several centers of excellence with a group of internationally renowned investigators that are at the forefront of oncology…
Given the increased focus on speed of activation for oncology studies, sponsors are under pressure to select top-performing investigative sites…